CPHI [CHINA PHARMA] DEF 14A:
[]
NCTY [The9] 6-K: (Original Filing)
[The9 Limited to Hold Annual General Meeting on December 4, 2017 Shanghai China, November 3, 2017 No proposal will be submitted for shareholder approval at the annual general meeting. Instead, the annual general meeting will serve as an open forum for shareholders of record and beneficial owners of t]
GSH [GUANGSHEN RAILWAY CO] 6-K: (Original Filing)
[(a joint stock limited company incorporated in the Peoples Republic of China) (Stock Code: 00525) THIRD QUARTERLY REPORT FOR 2017 The financial information set out in this quarterly report has not been audited, and has been prepared in accordance with the PRC Enterprise Accounting Standards. 1. IMP]
NCTY [The9] 6-K: The9 Limited to Hold Annual General Meeting on
[The9 Limited to Hold Annual General Meeting on December 4, 2017 Shanghai China, November 3, 2017 No proposal will be submitted for shareholder approval at the annual general meeting. Instead, the annual general meeting will serve as an open forum for shareholders of record and beneficial owners of t]
GSH [GUANGSHEN RAILWAY CO] 6-K: (a joint stock limited company incorporated in the
[(a joint stock limited company incorporated in the Peoples Republic of China) (Stock Code: 00525) THIRD QUARTERLY REPORT FOR 2017 The financial information set out in this quarterly report has not been audited, and has been prepared in accordance with the PRC Enterprise Accounting Standards. 1. IMP]
CHA [CHINA TELECOM] 6-K: (Original Filing)
[Number 1.1 Circular regarding proposed amendments to Articles of Association and notice of extraordinary general meeting, dated November 3, 2017 6-K our business and operating strategies and our ability to successfully execute these strategies; our network expansion and capital expenditure plans]
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac Biotech Announces Receipt of Delisting Determination Letter from Nasdaq BEIJING, November 3, 2017 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA)(”Sinovac”), a leading provider of biopharmaceutical products in China, announced today that on November 1, 2017, the Company received a delisti]
CHA [CHINA TELECOM] 6-K: Number 1.1 Circular regarding proposed amendments to Articles
[Number 1.1 Circular regarding proposed amendments to Articles of Association and notice of extraordinary general meeting, dated November 3, 2017 6-K our business and operating strategies and our ability to successfully execute these strategies; our network expansion and capital expenditure plans]
SVA [SINOVAC BIOTECH] 6-K: Sinovac Biotech Announces Receipt of Delisting Determination Letter
[Sinovac Biotech Announces Receipt of Delisting Determination Letter from Nasdaq BEIJING, November 3, 2017 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA)(”Sinovac”), a leading provider of biopharmaceutical products in China, announced today that on November 1, 2017, the Company received a delisti]
HNP [HUANENG POWER INTERNATIONAL] 6-K: (Original Filing)
[This Form 6-K consists of: Monthly Return of Equity Issuer on Movements in Securities For the month ended (dd/mm/yyyy) : 31/10/2017 To : Hong Kong Exchanges and Clearing Limited Name of Issuer Huaneng Power International, Inc Date Submitted 01/11/2017 I. Movements in Authorised Share Capital 1. Ordi]
